Smita Tukaram Kumbhar, Manish Sudesh Bhatia, and Shitalkumar Shivgonda Patil, “Engineered atenolol-glycoconjugates to target H9c2 cardiomyocyte cell lines”, ACTA INNOVATIONS, vol. 43, pp. 36–43, Jun. 2022.